The pharmaceutical industry saw some notable mergers and acquisitions in 2019; this article lists the top 10 by transaction size.
List view / Grid view
Drug makers have hiked the price of over 250 drugs in the US so far in 2020, according to new reports.
After regulatory approval, Bristol-Myers Squibb has announced its successful acquisition of Celgene, completing the merger.
The EMA CHMP has revealed its suggestion to grant marketing authorisation to seven medicines after its most recent meeting.